Sleep disturbance is common in several epilepsy types, such as juvenile myoclonic epilepsy (JME). Genetic background could increase susceptibility to seizure and sleep abnormalities. From this perspective, a susceptibility gene for sleep disturbance or chronotype could contribute to the genetic susceptibility threshold for epilepsy and vice versa. Accordingly, we investigated whether functional clock gene polymorphisms (PER2 111CNG, CLOCK 3111TNC, and PER3 VNTR) might influence the risk for JME. All these polymorphisms have recently been reported to be associated with sleep disturbance, diurnal variation, and neurological diseases. The polymorphisms were genotyped in 97 patients and 212 controls using polymerase chain reaction or restriction fragment length polymorphism methods. No significant differences were observed in the genotypic and allelic frequencies of these polymorphisms between cases and controls even when analyses were restricted to patients that presented a diurnal preferential seizure occurrence. We also tested for interactions between polymorphisms by multifactor dimensionality reduction analysis. None of the combined genotypes differed significantly between the groups. These results present no evidence for an association of these polymorphisms with JME. Further studies including other types of epilepsy and/or other functional polymorphisms are required to investigate the possible relationship between clock genes and the genetic susceptibility to chronic seizure.
Introduction
Juvenile myoclonic epilepsy (JME) is a subtype of common genetic generalized epilepsy with an estimated prevalence of 0.1-2 per 100 000 population and accounts for 10% of all forms of epilepsy [1] [2] [3] . Onset is at puberty with equal sex ratio, and it is characterized by myoclonic seizures, occasional generalized tonic-clonic seizures, and, sometimes, absence seizures [4] . The occurrence of myoclonic jerks early in the morning is one of the hallmarks of JME [5] . It is also highly drugresponsive since a frequent recurrence is reported after AED discontinuation [6] . The genetics of JME are complex and probably involves the interaction of multiple genes with minor effect and environmental factors [7] . In order to identify susceptibility genes for JME, an experimental approach directed to candidate genes selected according to their molecular function has been widely used in genetic association studies [8] .
Juvenile myoclonic epilepsy has a complex relationship with sleep, the latter affecting the former and vice versa. In fact, patients with JME have significant sleep disturbances characterized by excessive daytime sleepiness and disturbed night sleep, despite adequate medications and good seizure control [9, 10] . It was also observed that JME might contribute to the poor quality of sleep and that epileptiform activity occurs more often in sleep than wakefulness [11] . In JME, occurrence of seizures and epileptiform EEG discharges is influenced strongly by sleep deprivation [5, 12, 13] . Moreover, significant differences in morningness/eveningness distribution, timing of midsleep, and total sleep time were found between patients with epilepsy and healthy controls [14] .
Accumulating evidence indicates that clock genes regulate the sleep-wake cycle and circadian preference. Several clock genes, including PER1, PER2, PER3, CRY1, CRY2, BMAL1, CLOCK, and casein kinase 1 delta/epsilon (CK1D and CK1E), interact in translational-transcriptional autoregulatory feedback loops to generate circadian rhythms [15] . Among these genes, CLOCK, PER2, and PER3 are of particular interest since they contain functional polymorphisms which have recently been reported to be associated with sleep disturbance and diurnal preference [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] .
Indeed, the 3111TNC variation of the CLOCK gene (rs1801260) was the first to be reported affecting diurnal preference [16] . The genotype CLOCK rs1801260*CC was associated with evening preference, delayed sleep onset, and was characterized by shorter sleep time in comparison to the subjects with CLOCK rs1801260*T allele [17, 18] . The most studied PER2 variant is rs2304672, located at the 5′-UTR region, which has been associated with extreme morning preference [19] and advanced sleep phase syndrome (ASPS) [20] . Finally, PER3 contains a VNTR polymorphism (rs57875989) in the coding region, based on 4-repeat or 5-repeat alleles, which has been reported to be associated with delayed sleep phase syndrome [21, 22] and homeostatic sleep drive in healthy individuals [23] [24] [25] [26] [27] .
Furthermore, these genetic variations were consistently involved in the susceptibility to several neurological and chronic diseases, such as bipolar disorder [28, 29] , schizophrenia [30, 31] , and attention deficit hyperactivity disorder (ADHD) [32] [33] [34] . However, there are no reported studies that investigated if these or other variants of clock genes are associated with epilepsy, despite the fact that some of these genes presented an expression profile changed during the epileptogenic process in an animal model [35] .
We performed this case/control study to evaluate whether the PER2 rs2304672, CLOCK rs1801260 and PER3 rs57875989 polymorphisms might influence the risk for JME. In addition, a possible interaction among the three polymorphisms was investigated.
Materials and methods

Patients
This study included 309 individuals composed of 97 unrelated patients with JME and 212 healthy control subjects, all of whom were recruited from the state of Alagoas in northeastern Brazil. The study was approved by the Ethics Committee of the Federal University of Alagoas, Brazil (no. 004660/2011-71). Cases were matched with controls according to age, sex, and geographic location of origin. Individuals with a history of epileptic seizures or neuropsychiatric disorders were excluded from the control sample. The probands were unambiguously diagnosed cases of JME with classification based on the published criteria of the Commission on Classification and Terminology of the International League Against Epilepsy (ILAE) [36] . All patients were submitted to electroencephalography analysis, and only those with generalized spike wave were included in this study.
Genotyping
Using the FlexiGene DNA Kit (Qiagen, USA), DNA was extracted from peripheral blood leucocytes. Genotyping for rs1801260 and rs57875989 was performed as previously described in [21, 37] , respectively. For rs2304672 in PER2 gene, a total of 50 ng of genomic DNA was mixed with 5 pmol of each PCR primer in a total volume of 25 μL containing 1× PCR buffer (200 mM Tris-HCl pH 8.4, 500 mM KCl), 1.5 mM magnesium chloride, 0.2 mM of each deoxyribonucleotide triphosphate, and 0.5 U of DNA polymerase (Invitrogen, Carlsbad, CA). The primers 5′-GTGCGTGTGCTTGTTAATGC-3′ (forward) and 5′-TCCTTGGTGGGGTTAC TGG-3′ (reverse) were used to obtain PCR products of 114 bp size (GenBank accession no. ref. | NG_012146.1). The reaction mixture was cycled as follows in a DNA thermal cycler (BioCycler, MJ96G model): Denaturation at 94°C for 3 min was followed by 35 cycles at 94°C for 45 s, 55°C for 45 s, and 72°C for 45 s, and a final extension at 72°C for 7 min. A 20 μL aliquot of the PCR product was then submitted to restriction reaction at 37°C for 16 h with HpyCH4V restriction enzyme (Fermentas Life Sciences, USA). Fragments were separated by electrophoresis on 8% polyacrylamide gels and were visualized by ultraviolet light after staining with ethidium bromide. One uncut fragment of 114 bp is observed in the case of the rs2304672*CC genotype, whereas in the heterozygous samples, three fragments of 114 bp, 61 bp, and 53 pb can be observed. In the presence of the rs2304672*GG genotype, two fragments of 61 pb and 53 pb are observed.
Statistical analysis
All descriptive and statistical analyses for comparing clinical information between case and control groups and association with single variants were performed using SNPstats, a web-based tool offered by the Biostatistics and Bioinformatics Unit Web of The Catalan Institute of Oncology [38] . The following parameters were analyzed: Allele and genotype frequencies, Hardy-Weinberg disequilibrium, and SNP association with a response variable and odds ratio (OR) together with the 95% confidence interval (95% CI). We then estimated the OR adjusted for the clinical variables that were selected in the general linear model analysis with a logistic regression stepwise procedure. The selected variables evaluated were sex, pharmacological treatment, type of seizure, and genotype.
The statistical power of the sample for detecting association was performed by the G*Power v3.1.3 software [39] using the following parameters: logistic regression test, two-tail analysis, size sample = 309, minimum odds ratio (OR) = 1.5, and statistical significance level α = 0.05. In addition, multifactor dimensionality reduction (MDR) analysis was used in order to evaluate SNP-SNP interaction, using the MDR software [40] . Hypothesis testing and multiple comparisons adjustment were performed using the permutation approach of the MDR Permutation Test (beta 0.4.5) software, which generates empirical null distribution of prediction accuracy and compares it with the value of the final best model. We evaluated from one to four SNP combinations in our MDR analysis and used 10000 permutations for hypothesis testing. Significance was considered at both the 5% and 10% level for multivariate and MDR analysis.
Results
Demographic and clinical data of the unrelated patients with JME were reported previously [41] . Table 1 shows both allelic and genotypic frequencies of the studied polymorphisms in the two groups under study. The genotype distribution did not show Hardy-Weinberg disequilibrium as estimated by the chi-square test. Duplicated genotyping of 30% of the samples revealed 100% of concordance. Genotype and allele frequencies for the three polymorphisms studied did not differ significantly between the groups (Table 1 ) even when the OR was adjusted for the clinical variables (data not shown). We found that the study had a power of 80.25% to detect an association in our sample for a nominal significance level α of 0.05. In order to investigate a possible association in a restricted sample, we performed the genetic association analysis using just patients with JME that presented a diurnal preferential seizure occurrence and comparing them with control individuals. No differences were found between the groups (data not shown).
We also tested for interactions between polymorphisms comparing the patients with the control individuals. With the MDR analysis, we found that the best model for the interaction between rs1801260 (CLOCK) and rs57875989 (PER3) showed a testing balanced accuracy of 0.5614 and a cross-validation consistency of 10/10 ( Table 2) . None of the combined genotypes differed significantly between the groups (Table 2 ).
Discussion and conclusion
A susceptibility gene for sleep disturbance could contribute to the genetic susceptibility threshold for epilepsy and vice versa. In fact, mutations in the voltage-gated sodium channel (VGSC) gene SCN1A, for example, are responsible for both epilepsy disorders and sleep abnormalities, and recently, it was suggested that there is a common pathway for the clinical features (seizures and sleep abnormalities) associated with these mutations [42] . In this sense, we investigated whether the PER2 rs2304672, CLOCK rs1801260, and PER3 rs57875989 polymorphisms could influence the risk for JME. All these polymorphisms have recently been reported to be associated with sleep disturbance and diurnal variation. However, to the best of our knowledge, this is the first study investigating a possible association of polymorphisms in clock genes with epilepsy.
Our study included only the patients with JME rather than analyzing a clinically heterogeneous population with several epilepsy syndromes. This approach might have minimized possible bias from the limited sample size, which is a common problem in genetic association studies. We did not observe a significant difference in genotypic or allelic frequencies for these polymorphisms between the patients with JME and controls even when OR was adjusted for sex and/or ethnicity. Considering that each polymorphism may be only a weak contributor and the individual effects of each of these polymorphisms could not be observed, we also performed a genetic interaction analysis. For this, we utilized the recently developed MDR and interaction entropy strategy to access and interpret potential interaction among these genes. None of the combined genotypes differed significantly between the groups (Table 2) .
Heterogeneity represents the single biggest contributor to phenotype-related problems in genetic analysis of any common disease [43] . Restricting the dimension of a phenotype is a relevant way to maximize the chances of detecting epilepsy genetic risk factors. Then, we performed the genetic association analysis using just the patients with JME that presented a diurnal preferential seizure occurrence and compared them with the control individuals. Also, the allelic and genotypic frequencies for the three polymorphisms were not different between the groups.
These data suggest that the investigated PER2, CLOCK, and PER3 polymorphisms are not related to JME susceptibility, at least in this Brazilian sample. However, proof that association indeed does not exist would need replication of our findings in independent samples. Moreover, further studies including other types of epilepsy and/or other functional polymorphisms are required to investigate the relationship between clock genes and genetic susceptibility to chronic seizures.
Our data also contribute to the investigation of the frequency of PER2, CLOCK, and PER3 polymorphisms in the Brazilian population. Taking into account the general population, including both patient and control individuals, the allele frequencies of the polymorphisms observed in this study are the following: C (94%) and G (6%) for rs2304672, 4 repeats (66%) and 5 repeats (34%) for rs57875989, and T (78%) and C (22%) for rs1801260. These data are consistent with those observed in other worldwide subpopulations, suggesting that ethnic differences did not interfere in the distribution of these genetic variants [16, 17, 30, 37, [44] [45] [46] [47] .
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